Retrospective analysis of methylprednisolone treatment alone and in combination with methotrexate in patients with extensive alopecia areata

Basit Öğe Kaydı
dc.authorid0000-0002-8118-3405
dc.contributor.authorAltun, Ece
dc.contributor.authorYaylı, Savaş
dc.contributor.authorAksu Arıca, Deniz
dc.contributor.authorBaykal Selçuk, Leyla
dc.contributor.authorBahadır, Sevgi
dc.date.accessioned2022-12-01T12:22:06Z
dc.date.available2022-12-01T12:22:06Z
dc.date.issued2022
dc.departmentİstanbul Medipol Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, Deri ve Zührevi Hastalıklar Ana Bilim Dalı
dc.description.abstractAlopecia areata (AA) is a chronic autoimmune disorder that primarily affects the hair follicle. Systemic corticosteroids and methotrexate (MTX) are among the therapeutic options in severe cases. This study aimed to show whether the combination therapy of methylprednisolone (MP) and MTX was superior to MP alone in the management of extensive AA. A total of 26 patients with extensive AA, 14 treated with MP alone and 12 treated with the combination of MP and MTX, were retrospectively evaluated in terms of gender, age, severity of disease, clinical characteristics, disease duration, dose and duration of medications, therapy response, and side effects. Of the 26 patients with extensive AA, 14 were male and 12 were female, and the average age was 17.02 +/- 10.70 years. All patients had more than 50% hair loss, 23 had extensive multifocal AA, and three had alopecia totalis. A total of 14 patients were treated with MP alone (starting dose: 0.3-0.5 mg/kg, maximum 32 mg/day), and 12 were treated with MP + MTX (starting dose: 5-15 mg/week, maximum 20 mg/week). A total of 12 of the 14 patients (85.7%) who were treated with MP alone showed a complete response, with the response rate of the patients who showed more than 50% response being 92.85%. Seven of the 12 patients (58.3%) who were treated with MP + MTX achieved complete healing, and all patients on this regimen had more than 50% treatment response. Our results showed that the combination therapy of MP and MTX was not superior to MP alone in the management of extensive alopecia areata.
dc.identifier.citationAltun, E., Yaylı, S., Aksu Arıca, D., Baykal Selçuk, L. ve Bahadır, S. (2022). Retrospective analysis of methylprednisolone treatment alone and in combination with methotrexate in patients with extensive alopecia areata. Dermatologic Therapy, 35(10). https://doi.org/10.1111/dth.15776
dc.identifier.doi10.1111/dth.15776
dc.identifier.issn1396-0296
dc.identifier.issn1529-8019
dc.identifier.issue10
dc.identifier.pmid35986630
dc.identifier.scopus2-s2.0-85137221236
dc.identifier.scopusqualityQ2
dc.identifier.urihttps://doi.org/10.1111/dth.15776
dc.identifier.urihttps://hdl.handle.net/20.500.12511/10059
dc.identifier.volume35
dc.identifier.wos000847945600001en_US
dc.identifier.wosqualityQ2
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.institutionauthorAltun, Ece
dc.language.isoen
dc.publisherWiley
dc.relation.ispartofDermatologic Therapyen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/embargoedAccess
dc.subjectAlopecia Areata
dc.subjectMethotrexate
dc.subjectMethylprednisolone
dc.titleRetrospective analysis of methylprednisolone treatment alone and in combination with methotrexate in patients with extensive alopecia areata
dc.typeArticle

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Küçük Resim Yok
İsim:
Altun-Ece-2022.pdf
Boyut:
862.43 KB
Biçim:
Adobe Portable Document Format
Açıklama:
Tam Metin / Full Text
İndir
Lisans paketi
Listeleniyor 1 - 1 / 1
Küçük Resim Yok
İsim:
license.txt
Boyut:
1.44 KB
Biçim:
Item-specific license agreed upon to submission
Açıklama:
İndir

Koleksiyon

Makale Koleksiyonu
PubMed İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu
WoS İndeksli Yayınlar Koleksiyonu